About ABIONYX Pharma

Company Description

ABIONYX Pharma is a new-generation biotech company that aims to contribute to health through innovative therapies in indications where there is no effective or existing treatment, even the rarest ones

Thanks to its partners in research, medicine, its bioproduct suppliers and its shareholders, the company innovates on a daily basis to propose drugs for the treatment of renal and ophthalmological diseases, or new HDL vectors used for targeted drug delivery.

Headquarters

Bât. D2 33-43 Avenue Georges Pompidou, 31130 Balma – France

Shareholder information

Shares outstanding

27,914,274

IPO

March 30, 2015

Stock exchange(s)

Euronext Paris

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.